Antipsychotics Flashcards

1
Q

What are antipsychotics?

A
  • Drugs that reduce psychomotor excitement

* Controls symptoms of psychosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Therapeutic uses of antipsychotics

A
  1. Hallucination
  2. Delusions
  3. Agitation
  4. Psychomotor excitement
    - Mania
    - Schizophrenia
    - Psychosis 2ndary to medical condition
  5. Prophylaxis – prevent relapse of psychotic illness/episodes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

MOA of antipsychotics

A

• Blockade of DA pathways - reduces irrational behavior, agitation and aggressiveness along with psychotic symptomology
• In schizophrenia, DA overactivity is not the only abnormality
- Monoaminergic (5-HT) and aminoacid (glutamate) neurotransmitter systems may also be affected
• Only positive symptoms (hallucinations, aggression etc.) are linked with DA overactivity
• Negative symptoms (apathy, cognitive deficit etc.) are not necessarily linked with DA, however reduction of dopaminergic neurotransmission is the major mechanism of antipsychotic action.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Effect of DA antagonism on CVS

A

Hypotension (primarily postural) - d/t central and peripheral action on sympathetic tone

QT prolongation

Suppression of T wave (ECG)

Arrythmia (overdose)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Effect of DA antagonism on endocrine system

A

Increased prolactin release - d/t blockage of DA which has an inhibitory action on pituitary lactotrophs - gynaecomastia and galactorrhea, amenorrhea, hyperprolactinemia

Deacreased ADH - increased urine volume

Impair glucose tolerance - aggravate diabets, weight gain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Name the two classes of anti-psychotics

A

Typical

Atypical

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are typical antipsychotics? Give examples

A
•	Work primarily through inhibition of D2 receptor – extrapyramidal side effects
•	Reduced tendency to induce neurologic movement disorder 
•	Examples: 
a)	Chlorpromazine
b)	Thioridazine
c)	Fluphenazine
d)	Haloperidol
e)	Zuclopentixol
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are atypical antipsychotics?

A
•	Second generation anti-psychotics with weak dopamine blocking potential but strong 5-HT2 antagonistic activity. 
•	Minimal extrapyramidal SE and tardive dyskinesia 
•	Examples
a)	Risperidone 
b)	Clozapine 
c)	Olanzapine 
d)	Aripiprazole
e)	Quetiapine 
f)	Amisulpride
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Which class is used as the first line treatment?

A

Atypical antipsychotics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Chlorpromazine (receptors involved and SEs)

A
  • Receptor involved: alpha1, H1, muscarinic cholinergic
  • SE: sedation (blockade of alpha1 and histamine), hypotension (a1), anticholinergic (dry mouth, constipation, urinary incontinence), EPSE
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Haloperidol (receptors involved and SEs)

A
  • Receptor involved: dopamine receptor

* SE: high risk of EPSE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Risperidone (receptors involved and SEs)

A
  • Receptors involved: 5-HT2, D2 and alpha1

* SE: mild sedation, hypotension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Olanzapine (receptors involved and SEs)

A
  • Receptors involved: D2 (weak), anticholinergic, H1 (strong)
  • SE: sedation (H1), dry mouth, constipation, weight gain, metabolic syndrome (worsens diabetes)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Quetiapine (receptors involved and SEs)

A

• Receptors: 5-HT, D2, A1 and 2, H1, D2 (low)
• SE: sedation, postural hypotension, urinary retention/incontinence
- Extremely minimal EPSE and hyperprolactinaemic SE as D2 blocking activity is low

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Aripiprazole (receptors involved and SEs)

A
  • Receptors: partial dopamine agonist at D2 receptor, but antagonist at 5-HT2 receptor
  • SE: nausea, dyspepsia, constipation, light-headedness
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Clozapine

A

(used when unresponsive to other medication)
• Receptors: D2 (weak), 5-HT2 (strong), H1, alpha and muscarinic
• SE: sedation, potent anticholinergic, hypersalivation, agranulocytosis, bloody dyscrasia, precipitation of diabetes, myocarditis

17
Q

What monitoring is to be done when patient is on clozapine?

A
•	Regular blood tests are mandatory for a patient on clozapine to monitor the white cell count
-	First 6 months – weekly
-	Next 6 months – fortnightly 
-	Thereafter – every 4 weeks 
-	For one month after cessation
•	ECG
18
Q

List the extrapyramidal SE seen with conventional antipsychotics

A
  1. Acute dystonia – painful contractions of muscles in neck, jaw or eyes (more common in men)
  2. Parkinsonism – reduced facial movements, shuffling gait, stiffness, tremor
  3. Akathisia – involuntary restlessness (typically in the legs)
  4. Tardive dyskinesia – involuntary grimacing movements of the face, tongue or upper body
19
Q

List the general side effects seen with the use of atypical antipsychotics

A
  1. Weight gain - worst with clozapine and olanzapine
  2. Hyperglycaemia and type 2 diabetes - can induce this along with insulin resistance
  3. Metabolic syndrome the above two + dyslipidemia and HTN
  4. Stroke - caution with elderly patients and in dementia
20
Q

Treating acute dystonia

A

Stop antipsychotic AND/OR give anticholinergic

21
Q

Treatment of parkinsonism

A

Change antipsychotic - to something less D2 related

22
Q

Treating Akathisia

A

Reduce/ change antipsychotic

23
Q

Treating tardive dyskinesia

A

Sometimes reducing antipsychotics make it worse - not treatable

Therefore, prevent it rather than let it develop.

24
Q

Choosing antipsychotic

A

No real difference in efficacy

Consider previous use of antipsychotic - use what has helped before

Consider preexisting comobrbidties - diabetes, overwieght, parkinsons

Consider patient concerns for SE.

25
Use of depot
a) Detained patients who lack insight and will not take oral regularly b) Informal patients who recognise they can be irregular taking tablets or who prefers infrequent injection